IDPC and Instituto RIA argue that blanket prohibitions on practices to alter one's consciousness constitute unlawful limitations on the right to the freedom of thought.
EHRA publishes the results of its survey on OST in order to develop practical recommendations that will help decision-makers and health providers to refine their approaches on the subject.
The 1st Brandenburg Forum provided a trusted space for important discussion and debate to strengthen the drug policy focus within the key health and human rights bodies in Geneva.
EHRA provides a series of recommendations for those who seek to offer professional, comprehensive care for women who use drugs and experience gender-based violence (GBV).
C-EHRN provides advice to reduce the harms associated with the unintentional consumption of synthetic cannabinoids in contexts where drug checking services are not available.
The Center on Drug Policy Evaluation outlines drug policy reform and harm reduction priorities they believe the Biden administration should immediately act upon.
